Nicholas Boyd

Nicholas Boyd

Company: Cartherics

Job title: Chief Development Officer


Manufacture of Gene-Edited iPSC-Derived NK Cells for Solid Tumor Immunotherapy 2:30 pm

What are the important features for product-centric allogeneic immunotherapy, and how can we create this using iPSC? Lessons learned and implementation of gene-editing for developing master cell banks, and iNK differentiation Product development: translational studies toward the clinic with CTH-401Read more

day: Day 2 PM

Panel: The Bigger Picture: The Priorities of iPSC Based Cell Therapy Manufacturing 8:30 am

Identifying areas of focus during different developmental stages to ensure successful iPSC production and scale-up Managing operations and mitigating risk to ensure smooth transition through preclinical and clinical phasesRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.